Literature DB >> 3090550

Modulation of interleukin 2 receptor expression on normal human lymphocytes by thymic hormones.

M B Sztein, S A Serrate, A L Goldstein.   

Abstract

The expression of interleukin 2 receptors (IL-2R) is a critical step leading to normal lymphocyte proliferation. Since thymosin fraction 5 (TF5), a thymic hormone preparation, enhances lymphoproliferative responses of human cells, we examined the effects of TF5 on the expression of IL-2R on mitogen-stimulated human lymphocytes. TF5 significantly increased the percentage and antigen density of cells expressing IL-2R after stimulation with an optimal concentration of phytohemagglutinin (PHA) when the cells from the same donor exhibited suboptimal responses to PHA alone. The same effect was observed with a suboptimal PHA concentration and with OKT3 monoclonal antibody stimulation. Thymosin alpha 1, a synthetic polypeptide originally isolated in its native form from TF5, was also able to increase IL-2R expression in response to PHA, suggesting that it is the active species in TF5. The enhancement of IL-2R expression was paralleled by increased proliferative responses. Increased IL-2R expression appears to be the direct effect of thymic hormones, since abrogation of interleukin 2 production by cyclosporin A did not affect TF5-mediated enhancement of PHA-induced IL-2R expression. These results point to a physiological role of thymic hormones in the maintenance of normal levels of IL-2R expression. This immunoregulatory activity of thymic hormones might be relevant in the treatment of conditions where there is decreased IL-2R expression, such as the acquired immune-deficiency syndrome, or in the restoration of normal IL-2R expression to lymphocytes from aged individuals.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3090550      PMCID: PMC386448          DOI: 10.1073/pnas.83.16.6107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Purification and properties of bovine thymosin.

Authors:  J A Hooper; M C McDaniel; G B Thurman; G H Cohen; R S Schulof; A L Goldstein
Journal:  Ann N Y Acad Sci       Date:  1975-02-28       Impact factor: 5.691

Review 2.  Thymic hormones--a clinical update.

Authors:  M B Sztein; A L Goldstein
Journal:  Springer Semin Immunopathol       Date:  1986

3.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

4.  Thymosin treatment modulates production of interferon.

Authors:  K Y Huang; P D Kind; E M Jagoda; A L Goldstein
Journal:  J Interferon Res       Date:  1981

5.  The effect of experimental conditions on the assessment of T cell immunomodulation by biological response modifiers (thymosin fraction five).

Authors:  J E Talmadge; K L Benedict; K A Uithoven; B F Lenz
Journal:  Immunopharmacology       Date:  1984-02

6.  A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. II. Expression of Tac antigen on activated cytotoxic killer T cells, suppressor cells, and on one of two types of helper T cells.

Authors:  T Uchiyama; D L Nelson; T A Fleisher; T A Waldmann
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

7.  Triggering of the T3-Ti antigen-receptor complex results in clonal T-cell proliferation through an interleukin 2-dependent autocrine pathway.

Authors:  S C Meuer; R E Hussey; D A Cantrell; J C Hodgdon; S F Schlossman; K A Smith; E L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

8.  Expression of receptors for interleukin 2: Role in the commitment of T lymphocytes to proliferate.

Authors:  S Lipkowitz; W C Greene; A L Rubin; A Novogrodsky; K H Stenzel
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

9.  Thymic hormonal activity on human peripheral blood lymphocytes, in vitro. IV. Proliferative response to allogeneic tumor cells in healthy adults and cancer patients.

Authors:  J Shoham; I Eshel
Journal:  Int J Immunopharmacol       Date:  1983

10.  Transient expression of interleukin 2 receptors. Consequences for T cell growth.

Authors:  D A Cantrell; K A Smith
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

View more
  10 in total

1.  A pilot study of the safety and efficacy of thymosin alpha 1 in augmenting immune reconstitution in HIV-infected patients with low CD4 counts taking highly active antiretroviral therapy.

Authors:  D Chadwick; J Pido-Lopez; A Pires; N Imami; F Gotch; J S Villacian; S Ravindran; N I Paton
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

2.  A soluble factor from Trypanosoma brucei rhodesiense that prevents progression of activated human T lymphocytes through the cell cycle.

Authors:  M B Sztein; F Kierszenbaum
Journal:  Immunology       Date:  1991-06       Impact factor: 7.397

3.  Advances in the Treatment of Hepatitis B and Hepatitis C Nonresponders: A Report of Symposia Presented at the 15th Conference of the Asian Pacific Association for the Study of the LiverAugust 18-21, 2005Bali, Indonesia.

Authors: 
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-01

4.  Expression of alpha-thymosins in human tissues in normal and abnormal growth.

Authors:  O E Tsitsiloni; J Stiakakis; A Koutselinis; J Gogas; C Markopoulos; P Yialouris; S Bekris; D Panoussopoulos; V Kiortsis; W Voelter
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

5.  A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinoma.

Authors:  Robert G Gish; Stuart C Gordon; David Nelson; Vinod Rustgi; Israel Rios
Journal:  Hepatol Int       Date:  2009-05-08       Impact factor: 6.047

6.  Combination treatment using thymosin alpha 1 and interferon after cyclophosphamide is able to cure Lewis lung carcinoma in mice.

Authors:  E Garaci; A Mastino; F Pica; C Favalli
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

7.  Hematopoietic growth factor receptors.

Authors:  J H Shieh; M A Moore
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

8.  Circulating soluble interleukin 2 receptor concentration is increased in both immunogenic and nonimmunogenic hyperthyroidism.

Authors:  S Mariotti; P Caturegli; G Barbesino; G F Del Prete; L Chiovato; A Pinchera
Journal:  J Endocrinol Invest       Date:  1991-10       Impact factor: 4.256

9.  Interleukin-2-dependent control of disease development in spontaneously diabetic BB rats.

Authors:  J Zielasek; V Burkart; P Naylor; A Goldstein; U Kiesel; H Kolb
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

10.  Trypanosoma cruzi induces suppression of DNA synthesis and inhibits expression of interleukin-2 receptors by stimulated human B lymphocytes.

Authors:  F Kierszenbaum; E Moretti; M B Sztein
Journal:  Immunology       Date:  1991-10       Impact factor: 7.397

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.